68.24
price down icon0.47%   -0.32
pre-market  Pre-market:  71.98   3.74   +5.48%
loading

Arcellx Inc Stock (ACLX) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
37.83%
39.26
63.15 14.96 14.30 17.91
Operating Expenses
14.37%
55.07
48.15 59.82 43.86 48.37
Benefits Costs and Expenses
8.84%
46.45
42.68 54.30 38.44 44.93
Costs And Expenses
8.84%
46.45
42.68 54.30 38.44 44.93
Operating Income/Loss
205.41%
-15.81
15.00 -44.86 -29.56 -30.46
Income/Loss From Continuing Operations Before Tax
135.17%
-7.198
20.47 -39.34 -24.14 -27.02
Income Tax Expense/Benefit
100.00%
-
0.622 -0.006 -0.282 0.329
Income/Loss From Continuing Operations After Tax
136.27%
-7.198
19.84 -39.34 -23.85 -27.34
Net Income/Loss
136.27%
-7.198
19.84 -39.34 -23.85 -27.34
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
18,476%
52.76
0.284 48.44 48.11 46.77
Diluted Average Shares
18,476%
52.76
0.284 48.44 48.11 46.77
Basic Earnings Per Share
133.33%
-0.14
0.42 -0.81 -0.50 -0.58
Diluted Earnings Per Share
133.33%
-0.14
0.42 -0.81 -0.50 -0.58
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$80.78
price down icon 0.82%
$20.67
price down icon 0.53%
$353.75
price down icon 0.12%
$5.04
price down icon 2.14%
biotechnology ONC
$228.87
price up icon 0.53%
$119.94
price down icon 1.99%
Cap:     |  Volume (24h):